Human Milk Oligosaccharides: Pneumococcal Growth and Anti-Adhesion Effects
October 23, 2026
In tests with Streptococcus pneumoniae, 2'-fucosyllactose reduced bacterial adherence without supporting growth. That combination makes it a useful starting point for asking how milk oligosaccharides affect colonization beyond their role as nutrients.
Introduction
A Nature Communications study examines whether Streptococcus pneumoniae can use human milk oligosaccharides (HMOs) and whether these sugars inhibit bacterial adherence. Several HMOs supported growth under suitable culture conditions, whereas 2'-fucosyllactose (2'-FL) did not. The study also found that 2'-FL reduced adherence in cell models, supporting further investigation of its anti-adhesion activity.
The pneumococcus relies exclusively on carbohydrates for carbon and devotes a substantial share of its transport capacity to importing sugars. To test human milk oligosaccharides directly, the authors combined growth assays, transcriptomics, CRISPR interference screening, and NMR analysis of selected extracellular metabolites. These experiments address questions that complement HMO Profiling, while requiring separate measurements of substrate use and bacterial growth.
HMO-Supported Growth Depends on Culture Conditions
Six purified HMOs were tested: 2'-FL, 3-fucosyllactose, lacto-N-tetraose (LNT), lacto-N-neotetraose (LNnT), 3'-sialyllactose, and 6'-sialyllactose. Growth depended on the medium, sugar concentration, and prior growth on glucose or galactose. Galactose pre-growth generally supported more efficient HMO use. NMR directly showed depletion of LNnT and accumulation of free galactose and formate. The authors cautioned that weak growth with 3-fucosyllactose, and possibly LNT, could reflect contaminating metabolites; these compounds should not be described as unequivocally consumed. Transcriptomics of D39 grown on LNnT or 6'-sialyllactose revealed changes in carbohydrate transport, exoglycosidase, and galactose-processing pathways relative to lactose.

Fig. 1 Structures of six human milk oligosaccharides and condition-dependent growth of S. pneumoniae. (Bacher, et al., 2026)
A Genome-Wide CRISPRi Screen Identifies Catabolic Requirements
To find the machinery required for HMO use, the team performed a genome-wide CRISPR interference screen. Knockdown of the lacEFG-2 locus reduced fitness under several HMO growth conditions, but the effects differed by substrate. In particular, lacG-2 was important in the tested HMO media, whereas the lacEF-2 transporter genes did not show the same requirement for LNT and 3-fucosyllactose. Individual deletion mutants showed delayed or reduced growth rather than uniformly abolished growth. This functional approach complements HMO Compositional Profiling, which characterizes the substrates being tested.
The pre-growth experiments implicated carbon catabolite repression in HMO utilization. However, they did not establish why 2'-FL was not used as a growth substrate. Its lack of detectable utilization under the tested conditions should be distinguished from regulation of the HMOs that supported growth.
2'-Fucosyllactose Inhibits Adherence
Both lactose and 2'-FL reduced pneumococcal adherence to Detroit 562 cells in vitro, with no significant difference between them in that assay. In primary nasal epithelial cultures at the air-liquid interface, 2'-FL also reduced adherence. In adult mice given the sugars intranasally, nasopharyngeal bacterial counts were lower with 2'-FL than with lactose at the reported comparison points; lung counts did not differ significantly. These findings support an anti-adhesion hypothesis, but do not identify the bacterial binding site for 2'-FL or establish that it occupies host glycoconjugates.

Fig. 2 Nasopharyngeal and lung bacterial counts in adult mice given lactose or 2'-fucosyllactose intranasally. (Bacher, et al., 2026)
Connecting Glycan Metabolism to Microbe-Host Glycobiology
The study sits at the intersection of nutritional glycobiology and microbial pathogenesis. It separates HMO-supported growth from inhibition of bacterial adherence. Human Milk Oligosaccharide Microarray platforms can support binding studies, while Microbial Glycan Microarray Assay examines interactions involving microbial glycans. Neither type of array alone establishes HMO catabolism, which requires growth and substrate-consumption measurements.
The anti-adhesion findings also motivate studies across additional pneumococcal backgrounds. Microbe-focused Glycan Array Screening Service could support exploratory binding studies, followed by cell-based adherence assays and direct tests of the candidate interaction. The paper did not use glycan arrays to identify a 2'-FL receptor.
Nutritional Glycobiology of the Infant Airway
The pneumococcus colonizes the infant nasopharynx early, and nutrient availability may affect its persistence. The study examined isolated HMOs in culture and tested selected sugars in adult mice, rather than measuring HMO exposure in the infant airway. Whether naturally occurring airway concentrations reproduce the experimental effects remains to be established.
The combined growth and adherence experiments show why these outcomes need to be measured separately. A sugar can affect attachment without supporting detectable growth under the same conditions. The proposed competitive mechanism for 2'-FL remains to be tested directly, including identification of the relevant bacterial binding partner.
Implications for Milk-Oligosaccharide Supplementation
The findings justify further research on HMO structure and pneumococcal interactions, but do not demonstrate a benefit from adding 2'-FL to infant formula. The mouse experiments used intranasal administration, not oral feeding. Growth on selected HMOs in culture also does not by itself establish that dietary supplementation increases pathogen carriage.
Translation will need to account for mixtures of milk glycans, bacterial strain differences, exposure concentrations, and route of administration. Whether oral HMO supplementation changes infant airway colonization remains an open question. Studies addressing that question would need to distinguish nutritional effects from inhibition of adherence.
Future evaluation of HMO mixtures should therefore measure both substrate utilization and microbial attachment in relevant models. Such work could test whether the effects seen with isolated compounds persist in more complex conditions, without assuming that cell-culture or adult-mouse findings predict infant outcomes.
Outlook
The evidence that 2'-fucosyllactose limits pneumococcal adherence is promising, but several steps remain before it could inform infant health. The adult-mouse carriage findings need to be extended across strains and exposure conditions, the relevant bacterial interaction needs identification, and the relationship between oral intake and airway exposure requires study. The authors themselves call for further work on whether non-metabolizable 2'-fucosyllactose can be harnessed to limit adherence.
For glycoscience, the paper shows that HMO utilization and anti-adhesion activity depend on the structure and experimental context. That distinction is why Glycan Profiling and microbial interaction assays provide complementary information in host-microbe glycobiology.
Related Services & Products
Reference
- Bacher, K., et al. (2026). Metabolization of human milk oligosaccharides by Streptococcus pneumoniae. Nature Communications. DOI: 10.1038/s41467-026-77970-7.